Citation Impact
Citing Papers
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Bone density at various sites for prediction of hip fractures
1993 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Bone Formation Rate in Older Normal Women: Concurrent Assessment with Bone Histomorphometry, Calcium Kinetics, and Biochemical Markers*
1988
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study
2004
An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women
1996
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Hip Fracture and the Use of Estrogens in Postmenopausal Women
1987
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial
2002
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women
1995
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Cost Effectiveness of Screening Perimenopausal White Women for Osteoporosis: Bone Densitometry and Hormone Replacement Therapy
1990
Epidemiology of Hip Fractures
1997
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
RISK FACTORS FOR OSTEOPOROTIC FRACTURE
1998
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
1992 Standout
THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
1997
Osteoporosis. Frequency, consequences, and risk factors
1996
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study
1997
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
Production and Actions of Estrogens
2002 Standout
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Physical Activity in the Prevention and Amelioration of Osteoporosis in Women
2005
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
2004
Strategies for prevention of osteoporosis and hip fracture.
1991
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study
2003
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years
1988
Spinal Bone Loss and Ovulatory Disturbances
1990
Effect of Discontinuation of Estrogen, Calcitriol, and the Combination of Both on Bone Density and Bone Markers
2002
Involutional Osteoporosis
1986 Standout
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Effect of combined therapy with phosphate and calcitonin on bone volume in osteoporosis
1980
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered
1986
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Risedronate Increases Bone Mass in an Early Postmenopausal Population: Two Years of Treatment Plus One Year of Follow-Up1
1998
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Treatment of established osteoporosis: a systematic review and cost-utility analysis
2002
Estrogen and Coronary Heart Disease in Women
1991 Standout
Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation
1997 Standout
Estrogen-induced osteogenesis in intact female mice lacking ERβ
2002 StandoutNobel
Fractured Neck of Femur in the Elderly: An Attempt to Identify Patients at Risk
1979
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk—a perspective
2012
Postmenopausal osteoporosis : Proposed roles of defective coupling and estrogen deficiency
1981
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
1980
Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
1980
Interventions for preventing falls in older people living in the community
2012 Standout
PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN
1980
BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY
1981
Hip Fracture and the Use of Estrogens in Postmenopausal Women
1988
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites
2004 Standout
Works of Adh Clark being referenced
Bone loss during oestriol therapy in postmenopausal women
1979
BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT
1978
BONE RESPONSE TO TERMINATION OF OESTROGEN TREATMENT
1978